Sertraline for the treatment of depression in Alzheimer’s disease: Week-24 outcomes

BACKGROUND: Depression and antidepressant use are common in Alzheimer’s disease (AD), but the effect of antidepressant treatment for depression on longer-term outcomes is unknown. We report the week-24 outcomes of patients who participated in a 12-week efficacy study of sertraline for depression of...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Weintraub, Daniel, Rosenberg, Paul B., Drye, Lea T., Martin, Barbara K., Frangakis, Constantine, Mintzer, Jacobo E., Porsteinsson, Anton P., Schneider, Lon S., Rabins, Peter V., Munro, Cynthia A., Meinert, Curtis L., Lyketsos, Constantine G.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2010
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2849739/
https://ncbi.nlm.nih.gov/pubmed/20220589
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JGP.0b013e3181cc0333
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia